GCK's strong impact on glucose homeostasis and the fact that activating it lowers blood glucose levels regardless of the cause of hyperglycemia suggests that it may be a suitable therapeutic target for T2DM [7]. This evidence concerns the gene GCK and type 2 diabetes mellitus.